FDA Preemption: The Battle for Supremacy

• published: 13 Feb 2015
• views: 5

*This video has been edited. Portions of it were removed because the audio quality was poor.* For over a century, Americans have relied on the federal Food and Drug Administration (FDA) to regulate the quality and safety of everything from pharmaceutical products and medical devices to the labels on prepared foods. However, there is a growing trend in the courts that would allow lawsuits over these FDA approved items and their labels, effectively subjecting them to ad hoc regulation at the state level via litigation. On February 10, 2015, the New Jersey Civil Justice Institute hosted a panel discussion on this constantly evolving and critically important area of law with former Solicitor General Paul Clement of Bancroft PLLC; Gerald Masoudi of Covington & Burling LLP, who is the former Chief Counsel of the FDA; and Andrew Boczkowski, an Assistant General Counsel at GlaxoSmithKline. Additional information on this event, including a copy of the handouts, is available on the New Jersey Civil Justice Institute's website at: http://www.civiljusticenj.org/legal-experts-wary-of-growing-number-of-common-law-lawsuits-over-fda-approved-drugs/